Access to methadone clinics and opioid overdose deaths in Georgia: A geospatial analysis
- PMID: 35839618
- DOI: 10.1016/j.drugalcdep.2022.109565
Access to methadone clinics and opioid overdose deaths in Georgia: A geospatial analysis
Abstract
Background: As a result of the opioid epidemic, the demand for treatment options for opioid use disorder (OUD) such as methadone has increased. Methadone can only be administered in methadone clinics. Though numerous methadone clinics are located across the state of Georgia, access to methadone treatment may still be a concern for certain areas of the state. In this study, we examine the relationship between access to methadone clinics and opioid overdose death rates at the county level and compare access to treatment through Federally Qualified Health Centers (FQHCs) if methadone provision was to expand in Georgia.
Methods: We utilize location data for methadone clinics and FQHCs, and opioid overdose death rates at the county level from 2019 for the study analysis. The analysis was carried out using a geographical information system (GIS) mapping and a descriptive analysis.
Results: The results show that there is no methadone clinic accessible to individuals within a 15-minute drive time for 4 out of the 5 counties with the highest opioid overdose death rates in Georgia, though FQHCs are accessible within a 15-minute drive time to more than 67% of the population in each of these counties. Additionally, 7 out of the 9 counties with the highest opioid overdose death rates have no methadone clinic accessible within a 15-minute drive time, though all those counties have easier access to FQHCs.
Conclusion: If methadone distribution was to expand to FQHCs, more counties and a larger area of Georgia would have greater access to methadone treatment.
Keywords: Drive time; Federally qualified health center; Methadone access; Opioid use disorder.
Copyright © 2022 Elsevier B.V. All rights reserved.
Similar articles
-
Methadone Treatment Gap in Tennessee and How Medication Units Could Bridge the Gap: A Review.Pharmacy (Basel). 2023 Aug 22;11(5):131. doi: 10.3390/pharmacy11050131. Pharmacy (Basel). 2023. PMID: 37736904 Free PMC article. Review.
-
Expanding access to methadone treatment in Ohio through federally qualified health centers and a chain pharmacy: A geospatial modeling analysis.Drug Alcohol Depend. 2021 Mar 1;220:108534. doi: 10.1016/j.drugalcdep.2021.108534. Epub 2021 Jan 19. Drug Alcohol Depend. 2021. PMID: 33497963 Free PMC article.
-
A Spatial Epidemiologic Analysis of Opioid Use Disorder Treatment in New York State.Med Care. 2025 May 1;63(5):386-392. doi: 10.1097/MLR.0000000000002142. Epub 2025 Mar 12. Med Care. 2025. PMID: 40072214
-
Association of Medicaid Expansion With Opioid Overdose Mortality in the United States.JAMA Netw Open. 2020 Jan 3;3(1):e1919066. doi: 10.1001/jamanetworkopen.2019.19066. JAMA Netw Open. 2020. PMID: 31922561 Free PMC article.
-
Novel Therapeutic and Program-Based Approaches to Opioid Use Disorders.Annu Rev Med. 2024 Jan 29;75:83-97. doi: 10.1146/annurev-med-050522-033924. Epub 2023 Oct 12. Annu Rev Med. 2024. PMID: 37827194 Review.
Cited by
-
Narrative minireview of the spatial epidemiology of substance use disorder in the United States: Who is at risk and where?World J Clin Cases. 2023 Apr 16;11(11):2374-2385. doi: 10.12998/wjcc.v11.i11.2374. World J Clin Cases. 2023. PMID: 37123313 Free PMC article. Review.
-
Methadone Treatment Gap in Tennessee and How Medication Units Could Bridge the Gap: A Review.Pharmacy (Basel). 2023 Aug 22;11(5):131. doi: 10.3390/pharmacy11050131. Pharmacy (Basel). 2023. PMID: 37736904 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials